China cardiovascular diseases report 2015: a summaryWei-Wei CHEN, Run-Lin GAO, Li-Sheng LIU, Man-Lu ZHU, Wen WANG, Yong-Jun WANG, Zhao-Su WU1-10
How to select the appropriate candidate of pulmonary arterial hypertension:specific therapy in elderly patients with pulmonary hypertensionYalin Tolga Yaylali17-19
Clinical and hemodynamic profiles of elderly patients with pulmonary arterial hypertension: a single center, prospective studyEbru Ozpelit, Bahri Akdeniz, Dilek Sezgin, Can Sevinc, Kemal Can Tertemiz, Mehmet Emre Ozpelit, Mustafa Baris20-27
Which prognostic factors should be used in pulmonary arterial hypertension in elderly patients?Bahri Akdeniz28-34
Nine-year clinical outcomes of drug-eluting stents vs.bare metal stents for large coronary vessel lesionsDong YIN, Jia LI, Yue-Jin YANG, Yang WANG, Yan-Yan ZHAO, Shi-Jie YOU, Shu-Bin QIAO35-41
Conditions for autonomous choice: a qualitative study of older adults' experience of decision-making in TAVRElisabeth Skaar, Anette Hylen Ranhoff, Jan Erik Nordrehaug, Daniel E Forman, Margrethe Aase Schaufel42-48
Admission white blood cell count predicts short-term clinical outcomes in patients with uncomplicated Stanford type B acute aortic dissectionZhao-Ran CHEN, Bi HUANG, Hai-Song LU, Zhen-Hua ZHAO, Ru-Tai HUI, Yan-Min YANG, Xiao-Han FAN49-56
Liraglutide directly protects cardiomyocytes against reperfusion injury possibly via modulation of intracellular calcium homeostasisShun-Ying HU, Ying ZHANG, Ping-Jun ZHU, Hao ZHOU, Yun-Dai CHEN57-66
New generations of dihydropyridines for treatment of hypertensionAngela L Wang, Costantino Iadecola, Gang Wang67-72
